RNA Viruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892;
RNA Viruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892.
Proc Natl Acad Sci U S A. 2021 Mar 30;118(13). doi: 10.1073/pnas.2020969118.
Recoding viral genomes by introducing numerous synonymous but suboptimal codon pairs-called codon-pair deoptimization (CPD)-provides new types of live-attenuated vaccine candidates. The large number of nucleotide changes resulting from CPD should provide genetic stability to the attenuating phenotype, but this has not been rigorously tested. Human respiratory syncytial virus in which the G and F surface glycoprotein ORFs were CPD (called Min B) was temperature-sensitive and highly restricted in vitro. When subjected to selective pressure by serial passage at increasing temperatures, Min B substantially regained expression of F and replication fitness. Whole-genome deep sequencing showed many point mutations scattered across the genome, including one combination of six linked point mutations. However, their reintroduction into Min B provided minimal rescue. Further analysis revealed viral genomes bearing very large internal deletions (LD genomes) that accumulated after only a few passages. The deletions relocated the CPD F gene to the first or second promoter-proximal gene position. LD genomes amplified de novo in Min B-infected cells were encapsidated, expressed high levels of F, and complemented Min B replication This study provides insight on a variation of the adaptability of a debilitated negative-strand RNA virus, namely the generation of defective minihelper viruses to overcome its restriction. This is in contrast to the common "defective interfering particles" that interfere with the replication of the virus from which they originated. To our knowledge, defective genomes that promote rather than inhibit replication have not been reported before in RNA viruses.
通过引入大量同义但次优的密码子对(称为密码子对去优化(CPD))来重新编码病毒基因组,为新型活减毒疫苗候选物提供了新的类型。由于 CPD 产生的大量核苷酸变化应该为减毒表型提供遗传稳定性,但这尚未经过严格测试。人类呼吸道合胞病毒(RSV)中 G 和 F 表面糖蛋白 ORF 进行了 CPD(称为 Min B),它具有温度敏感性并且在体外受到高度限制。当在逐渐升高的温度下通过连续传代受到选择压力时,Min B 会大大恢复 F 的表达和复制适应性。全基因组深度测序显示,基因组中散布着许多点突变,包括一个六个连锁点突变的组合。然而,将它们重新引入 Min B 中提供的挽救作用很小。进一步的分析表明,仅在少数传代后就积累了带有非常大内部缺失(LD 基因组)的病毒基因组。这些缺失将 CPD F 基因重新定位到第一个或第二个启动子近端基因位置。在 Min B 感染的细胞中从头扩增的 LD 基因组被包装,并表达高水平的 F,补充 Min B 的复制。本研究提供了对一种削弱的负链 RNA 病毒适应性变化的深入了解,即产生缺陷的小型辅助病毒以克服其限制。这与常见的“缺陷干扰颗粒”形成对比,后者干扰其起源的病毒的复制。据我们所知,以前在 RNA 病毒中没有报道过促进而不是抑制复制的缺陷基因组。